<DOC>
	<DOCNO>NCT02068768</DOCNO>
	<brief_summary>The purpose prospective clinical study examine short-term safety efficacy Avenue®- L interbody Spinal Fusion System VerteBRIDGE® plat treat one two level degenerative disc disease L2 S1 focus fusion rate .</brief_summary>
	<brief_title>Multicenter Study Avenue L Interbody Spinal Fusion System Using VerteBRIDGE Plating Posterior Fixation</brief_title>
	<detailed_description />
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>Subjects must candidate onlabel use Avenue L device ( degenerative disc disease , use one two contiguous level , posterior fixation must use , autograft must use interbody cage ) Subject must skeletally mature time surgery , i.e . subject must least 21 year age time surgery Subject minimum 6 month nonoperative treatment prior surgery The placement Avenue L device must primary surgery Subject must willing sign consent form able return follow visit . Subject must prior surgery operative level ( ) Subject know substance alcohol addiction Subject lateral curvature spine ( scoliosis , type ) Subject prisoner Subject pregnant Subject active infection sepsis time surgery Subject neuromuscular disorder would preclude accurate neurologic evaluation</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>fusion</keyword>
	<keyword>lateral interbody fusion system</keyword>
	<keyword>lumbar spine</keyword>
	<keyword>degenerative disc disease</keyword>
</DOC>